Artventive Medical Group Inc (AVTD) financial statements (2021 and earlier)

Company profile

Business Address 2766 GATEWAY ROAD
CARLSBAD, CA 92009
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments306102253209
Cash and cash equivalents306102253209
Inventory, net of allowances, customer advances and progress billings7247311303304197
Inventory7247311303304197
Prepaid expense2461211
Other undisclosed current assets41825185771
Total current assets:14666353355416478
Noncurrent Assets
Property, plant and equipment141538171516
Other undisclosed noncurrent assets16568211597
Total noncurrent assets:14219399130114
TOTAL ASSETS:16086446453546591
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,8771,6471,445924604476
Accounts payable1,8771,6471,445924604476
Employee-related liabilities    00
Debt    500 
Due to related parties500500    
Other undisclosed current liabilities(500)(500)  (500) 
Total current liabilities:1,8771,6471,445924604476
Noncurrent Liabilities
Long-term debt and lease obligation500500500500500500
Long-term debt, excluding current maturities500500500500500500
Total noncurrent liabilities:500500500500500500
Total liabilities:2,3772,1471,9451,4241,104976
Stockholders' equity
Stockholders' equity attributable to parent, including:(2,217)(2,060)(1,499)(971)(558)(385)
Additional paid in capital17,19517,08817,04317,02916,67915,922
Accumulated deficit    (17,300)(16,369)
Other undisclosed stockholders' equity attributable to parent(19,412)(19,148)(18,542)(17,999)6362
Total stockholders' equity:(2,217)(2,060)(1,499)(971)(558)(385)
TOTAL LIABILITIES AND EQUITY:16086446453546591

Income statement (P&L) ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
Revenues1121946225094
Cost of revenue
(Cost of Goods and Services Sold)
(54)(19)(46)(22)(50)(94)
Gross profit:58     
Operating expenses(362)(526)(543)(766)(930)(964)
Other undisclosed operating income (loss)   3(1)(1)
Operating loss:(304)(526)(543)(763)(931)(965)
Net loss:(304)(526)(543)(763)(931)(965)
Other undisclosed net income attributable to parent   0  
Net loss attributable to parent:(304)(526)(543)(763)(931)(965)
Other undisclosed net income (loss) available to common stockholders, basic   (0)00
Net loss available to common stockholders, diluted:(304)(526)(543)(763)(931)(965)

Comprehensive Income ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
Net loss:(304)(526)(543)(763)(931)(965)
Comprehensive loss:(304)(526)(543)(763)(931)(965)
Other undisclosed comprehensive income, net of tax, attributable to parent   000
Comprehensive loss, net of tax, attributable to parent:(304)(526)(543)(763)(931)(965)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: